NCT00150488View on ClinicalTrials.gov

URACYST® For the Treatment of GAG Deficient Interstitial Cystitis

NACompletedINTERVENTIONAL

Enrollment

53

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

February 29, 2008

Conditions

Painful Bladder SyndromeInterstitial Cystitis

Interventions

DEVICE

Uracyst

2% weekly for 6 weeks, monthly for 4 months

Trial Locations (1)

K7L 3N6

Centre for Advanced Urological Research, Kingston General Hospital, Kingston

Sponsors

Collaborators (1)

Stellar Pharmaceuticals

All Listed Sponsors

collaborator

Stellar Pharmaceuticals

INDUSTRY

lead

Dr. J. Curtis Nickel

OTHER